Physician profile
Robert Evan Levy
NPI 1619397635
$2,618.29
in general payments reported to CMS, 2019-2025
23 companies · $670 in 2025
The $670 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $219 · 2021: $351 · 2022: $427 · 2023: $278 · 2024: $559 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,490 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,489.56 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $587.60 | 2019-2023 | Tepezza |
| Alcon Vision LLC | $454.40 | 2019-2025 | Clareon Panoptix Pro, Tryptyr, Rocklatan |
| Abbvie INC. | $372.66 | 2022-2025 | |
| Amgen INC. | $302.19 | 2024 | Tepezza |
| Sun Pharmaceutical Industries INC. | $110.32 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $95.48 | 2019-2022 | |
| Abbott Laboratories | $74.72 | 2022 | |
| Aerie Pharmaceuticals, INC. | $73.23 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $69.19 | 2022-2024 | Acthar |
| Oyster Point Pharma, INC. | $67.91 | 2022-2024 | Tyrvaya |
| Dompe US, INC. | $58.29 | 2022-2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $53.95 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $52.93 | 2022-2023 | Miebo, Vyzulta |
| Baxter Healthcare | $41.51 | 2025 | Perclot |
| Kala Pharmaceuticals, INC. | $36.60 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $28.18 | 2025 | Vabysmo |
| Pacira Pharmaceuticals Incorporated | $27.39 | 2025 | Exparel |
| Allergan, INC. | $23.59 | 2021 | |
| New World Medical,INC. | $20.43 | 2024 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Stryker Corporation | $18.03 | 2025 | Xerogel |
| Galderma Laboratories, L.P. | $18.00 | 2025 | |
| Eyevance Pharmaceuticals LLC | $12.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.